| Breakdown | TTM | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 98.16M | 100.39M | 108.64M | 111.98M | 112.20M | 93.76M |
| Gross Profit | 65.00M | 68.44M | 73.68M | 70.30M | 69.56M | 49.47M |
| EBITDA | 6.74M | -7.75M | 16.11M | 12.68M | 17.12M | 12.53M |
| Net Income | -15.26M | -15.24M | 8.20M | 8.82M | 7.76M | 3.83M |
Balance Sheet | ||||||
| Total Assets | 96.25M | 97.20M | 110.64M | 107.33M | 105.73M | 99.68M |
| Cash, Cash Equivalents and Short-Term Investments | 7.76M | 5.81M | 16.34M | 15.40M | 19.05M | 15.55M |
| Total Debt | 10.88M | 11.23M | 5.15M | 5.12M | 3.90M | 6.29M |
| Total Liabilities | 27.01M | 28.47M | 24.11M | 26.01M | 26.02M | 32.92M |
| Stockholders Equity | 69.24M | 68.73M | 86.53M | 81.32M | 79.71M | 66.76M |
Cash Flow | ||||||
| Free Cash Flow | 4.03M | -6.14M | 5.83M | 856.00K | 6.78M | 16.85M |
| Operating Cash Flow | 4.92M | -2.06M | 9.09M | 5.64M | 8.91M | 17.92M |
| Investing Cash Flow | -1.88M | -3.95M | -3.04M | -4.79M | -2.13M | -1.00M |
| Financing Cash Flow | -4.61M | -4.57M | -4.95M | -4.90M | -3.22M | -2.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £56.05M | 3.42 | 20.89% | 0.55% | 2.64% | 23.89% | |
68 Neutral | £37.54M | 8.53 | 12.14% | 11.65% | -3.45% | -44.02% | |
64 Neutral | £33.54M | 7.91 | 8.31% | 7.98% | -3.45% | -35.25% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | £303.88M | 4.43 | 9.74% | ― | 4.38% | ― | |
49 Neutral | £39.38M | 9.31 | -22.13% | 3.45% | -4.23% | -435.86% | |
48 Neutral | £12.75M | -1.63 | 0.16% | ― | -3.72% | ― |